Skip to main content

Table 4 Treatment response

From: LABS score– a prognostic tool for FOLFOX4-treated advanced hepatocellular carcinoma and real-world efficacy: a single-center retrospective study

 

Entire cohort

(n = 58)

First-line cohort

(n = 44)

Later-line cohort

(n = 14)

Complete response, n (%)

0 (0)

0 (0)

0 (0)

Partial response, n (%)

5 (8.6)

3 (6.8)

2 (14.3)

Stable disease, n (%)

12 (20.7)

7 (15.9)

5 (35.7)

Progressive disease, n (%)

13 (22.4)

10 (22.7)

3 (21.4)

ORR per ITT, n (%)

5 (8.6)

3 (6.8)

2 (14.3)

ORR per assessable, n (%)

5 (16.7)

3 (15)

2 (20)

DCR per ITT, n (%)

17 (29.3)

10 (22.7)

7 (50)

DCR per assessable, n (%)

17 (56.7)

10 (50)

7 (70)

  1. ORR, objective response rate; DCR, disease control rate